In a study of patients with COVD-19, 93% of severe and critically ill patients had hypokalemia.
Could this be contributing to increased mortality in such patients due to risk of fatal arrhythmias?
Hypokalemia as well as Hypomagnesemia could fascilitate the occurrence of TdP because of QTc prolongation, thus adding to this risk especially in Covid 19 patients on Hydroxychloriquine/Azithromycin and/or Myocarditis.
Challenging to correct because of continuous renal loss owing to the degradation of ACE2.
Hypokalemia is prevailing in patients with COVID-19. The correction of hypokalemia is challenging because of continuous renal K+ loss resulting from the degradation of ACE2. The end of urine K+ loss indicates a good prognosis and may be a reliable, in-time, and sensitive biomarker directly reflecting the end of adverse effect on RAS system.